Snack Foods and Their Impact on the Immune Response Following Influenza Vaccination
NCT05515263 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 88
Last updated 2023-07-27
Summary
The purpose of this study is to evaluate the impact of replacing usual snacks with alternative snack foods on the immune response to influenza vaccination in a population of healthy, middle-aged adults.
Conditions
- Immune Response
Interventions
- DIETARY_SUPPLEMENT
-
Intervention snack
To be eaten in replacement of usual snacks twice a day for 8 weeks.
- DIETARY_SUPPLEMENT
-
Control snack
To be eaten in replacement of usual snacks twice a day for 8 weeks.
Sponsors & Collaborators
- lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 40 Years
- Max Age
- 64 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-09-09
- Primary Completion
- 2024-06-30
- Completion
- 2024-06-30
Countries
- United Kingdom
Study Locations
More Related Trials
-
Immunologic Response to Inactivated Vaccine for Novel H1N1 Virus
NCT01023711 ·Status: COMPLETED ·Phase: NA
-
Safety, Tolerability, Efficacy and Immunogenicity of an Influenza A Vaccine (FP-01.1) in Healthy Volunteers Following Virus Challenge
NCT02071329 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Adults
NCT00951041 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety and Immunogenicity Evaluation of Live Attenuated Influenza Vaccine
NCT05056519 ·Status: UNKNOWN ·Phase: PHASE1
-
Immunogenicity and Safety Study of an Investigational Influenza (H1N1 Influenza Virus) Vaccine in Adults
NCT00989287 ·Status: COMPLETED ·Phase: PHASE3
-
Th1 Response to Influenza: Aging and Vaccine Efficacy
NCT00396305 ·Status: TERMINATED ·Phase: PHASE4
-
Immunologic Response to Influenza Vaccination in Children and Adolescents
NCT03614975 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Assess Safety of an Inactivated H5N1 Influenza Vaccine Administered in GelVac Nasal Powder to Healthy Young Adults
NCT01258062 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity of One Dose of a Surface, Antigen, Inactivated, Influenza Vaccine Produced in Mammalian Cell Culture Administered to Adult and Elderly Subjects
NCT01422512 ·Status: COMPLETED ·Phase: PHASE3
-
Age and Response to Flu Vaccines
NCT03328325 ·Status: COMPLETED ·Phase: PHASE4
-
Early Immune Responses to Inactivated Influenza Vaccine: a Pilot Study
NCT01522248 ·Status: COMPLETED ·Phase: NA
-
Half-Dose Flu Vaccine Study in Healthy Adults
NCT00006146 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Biomarkers of Immune Activation Associated with Symptoms and Immune Responses After Influenza Vaccination in Adults
NCT03160118 ·Status: COMPLETED ·Phase: PHASE4
-
Persistence of Immune Response After Vaccination With Influenza Vaccine
NCT01906190 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate the Immunogenicity & Safety of an Investigational Influenza Vaccine (H1N1) in Adults
NCT00968539 ·Status: COMPLETED ·Phase: PHASE3
-
Vaccination Efficacy With Metformin in Older Adults
NCT03996538 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Human Immune Responses to Influenza Virus Vaccination in Healthy Volunteers
NCT02385123 ·Status: TERMINATED ·Phase: PHASE4
-
A Study to Evaluate the Safety and Immunogenicity of an Inactivated Split-virion Influenza A(H1N1) Vaccine
NCT01201902 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older
NCT00979602 ·Status: COMPLETED ·Phase: PHASE3
-
Self-Administered Nasal Influenza Feasibility Study
NCT01933048 ·Status: COMPLETED ·Phase: PHASE4
-
Study of the Ability of a Flu Vaccine to Prevent Flu Infection
NCT00349037 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Blueberries on Immunity
NCT05534893 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Adults
NCT00968526 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2007/2008) When Administered to Elderly Subjects
NCT00522236 ·Status: COMPLETED ·Phase: PHASE2
-
The Immunogenicity and Safety of 2013-2014 Seasonal Trivalent Influenza Vaccine
NCT02269852 ·Status: COMPLETED ·Phase: PHASE4